Celecoxib, a cyclooxygenase-2 (COX-2) inhibitor, could downregulate NGF, relieving chronic pain due to head and neck squamous cell carcinoma (HNSCC) (Yang et al. 2015a, b). The gene discussed is NGF; the disease is head and neck squamous cell carcinoma.